Billionaire Bill Ackman has never been reluctant to blaze trails. He became the first hedge fund manager to get directly involved in a hostile takeover when backed Valeant Pharmaceuticals' $50 billion bid for Allergan. And Ackman is leading a costly and very public crusade against Herbalife, which he says is little more than a pyramid scheme. Now he's considering listing his offshore fund in London, a move that would free him from the whims of wimpy investors. But potential shareholders should beware. Ackman's recent record is mixed, at best. And his brand of activist investing will never be as big across the pond as it is in the U.S.

More from Video

3 Things to Know at Market Close: Jamie Dimon's the King of Wall Street

3 Things to Know at Market Close: Jamie Dimon's the King of Wall Street

Striking Options: Crude Oil Volatility and Mixed Global Economic Data

Striking Options: Crude Oil Volatility and Mixed Global Economic Data

Jim Cramer's 10 Lessons for a Bear Market

Jim Cramer's 10 Lessons for a Bear Market

Does Davos Matter Anymore? Why Jim Cramer Says It Will Play Less of a Role

Does Davos Matter Anymore? Why Jim Cramer Says It Will Play Less of a Role

In Case You Missed it: Stocks Face Headwinds Times 10, IBM Earnings

In Case You Missed it: Stocks Face Headwinds Times 10, IBM Earnings